NASDAQ:AUPH

Aurinia Pharmaceuticals Earning Date

USA |NASDAQ |USD

AUPH Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.33 $-0.37 $-0.28
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $13.88M $6.62M $29.00K

Aurinia Pharmaceuticals's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

AUPH Earnings Date & History Chart

AUPH Earnings & Revenue Forecast

AUPH Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $-0.24 $-0.29 $-0.19
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $-1.34 $-1.45 $-1.23
Dec 2022 7 $-0.37 $-0.80 $0.02

AUPH Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.24 $0.00 $0.00
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.34 $0.08 $0.08
Dec 2022 0 / 0 $-0.37 $1.28 $1.28

AUPH Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 8 $24.21M $20.50M $28.67M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $45.60M $40.00M $51.76M
Dec 2022 8 $208.20M $135.00M $268.08M

AUPH Earnings Date & Revenue History

AUPH Earnings History

|
Show More
Show More

AUPH Revenue History

|
Show More
Show More

Aurinia Pharmaceuticals Next Earnings Date & Report

AUPH Next Earnings Date & Report Preview: Sep 2021 (FQ)

AUPH's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 7 analysts, the average EPS estimation for Aurinia Pharmaceuticals's next quarterly earnings is $-0.33, with a low EPS estimation of $-0.38, and a high estimation of $-0.30.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.33, the last 2 month trend is $0.00, and the 3 month trend is $0.00.

Based on 3 analysts, the average revenue estimation is $13.88M, with a low revenue estimation of $11.81M, and a high estimation of $15.56M.

Aurinia Pharmaceuticals Previous Earnings Dates & Reports

AUPH Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Aurinia Pharmaceuticals's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

AUPH's earnings per share (EPS) was $-0.37, missing the consensus analysts forecast of $-0.37 by -1.37%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -7.50%, and lower than the same period a year before (Jun 2020) by 42.31%.

Revenues were $6.62M, better than the forecast of $6.62M by 0.00%, up by 624.29% from the previous quarter , and up by 22727.59% from the same period last year.

The company reported a net income of $-47.01M.

Free cash flow for the quarter was $-38.20M , compared to $-54.72M last quarter and $-22.73M a year before.

AUPH ended the quarter with $8.94M in total debt, an increase of 0.62% compared to the previous quarter, and an increase of 44.08% compared to the same quarter a year before.

AUPH Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aurinia Pharmaceuticals's previous annual earnings date was Feb 24, 2021 for its fiscal year ended Dec 31, 2020.

AUPH's earnings per share (EPS) was $-0.74.

Revenues were $50.12M, up by 15660.38% from previous year's revenue.

The company reported a net income of $-102.68M.

Aurinia Pharmaceuticals reported a free cash flow of $-77.20M for its fiscal year, compared to $-63.56M a year ago.

The company ended the fiscal year with $8.41M in total debt. lala